GlassScriptPhysician profile
David M Paulson
NPI 1912026519
$4,305.91
in general payments reported to CMS, 2019-2025
44 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,014 · 2022: $1,677 · 2023: $336 · 2024: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $555.56 | 2021-2024 | Ztlido |
| Amgen INC. | $438.71 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $276.63 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $265.32 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $238.22 | 2021 | |
| Abbvie INC. | $230.80 | 2021-2024 | |
| Biogen, INC. | $197.97 | 2021-2022 | |
| Forte Bio-Pharma LLC | $190.98 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $170.75 | 2022 | |
| Abbott Laboratories | $152.60 | 2022-2023 | Proclaim |
| Allergan, INC. | $145.12 | 2021 | |
| Redhill Biopharma INC. | $134.17 | 2021 | |
| Almatica Pharma LLC | $125.75 | 2021 | |
| Jazz Pharmaceuticals INC. | $102.77 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $94.05 | 2021-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Paulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.